 Lisa Brenner
Concepts (567)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 152 | 2025 | 1476 | 23.810 |
Why?
| | Suicide | 60 | 2025 | 656 | 12.110 |
Why?
| | Brain Injuries, Traumatic | 30 | 2024 | 360 | 9.710 |
Why?
| | Brain Injuries | 43 | 2024 | 494 | 8.560 |
Why?
| | Military Personnel | 39 | 2025 | 544 | 8.040 |
Why?
| | Stress Disorders, Post-Traumatic | 42 | 2025 | 847 | 6.910 |
Why?
| | Brain Concussion | 28 | 2025 | 574 | 6.700 |
Why?
| | Suicidal Ideation | 40 | 2025 | 529 | 6.050 |
Why?
| | United States Department of Veterans Affairs | 48 | 2025 | 678 | 5.760 |
Why?
| | Suicide, Attempted | 30 | 2025 | 378 | 5.240 |
Why?
| | Occupational Therapy | 6 | 2025 | 100 | 4.630 |
Why?
| | Microbiota | 14 | 2025 | 762 | 3.900 |
Why?
| | Mental Disorders | 21 | 2025 | 1077 | 3.720 |
Why?
| | United States | 121 | 2025 | 14841 | 3.580 |
Why?
| | Post-Concussion Syndrome | 10 | 2024 | 175 | 2.940 |
Why?
| | Veterans Health | 13 | 2024 | 186 | 2.820 |
Why?
| | Mental Health | 19 | 2025 | 726 | 2.730 |
Why?
| | Depressive Disorder, Major | 14 | 2025 | 364 | 2.670 |
Why?
| | Humans | 267 | 2025 | 137585 | 2.510 |
Why?
| | Health Services Accessibility | 8 | 2025 | 986 | 2.390 |
Why?
| | Adult | 132 | 2025 | 37929 | 2.270 |
Why?
| | Blast Injuries | 8 | 2024 | 48 | 2.250 |
Why?
| | Iraq War, 2003-2011 | 19 | 2024 | 127 | 2.190 |
Why?
| | Middle Aged | 111 | 2025 | 33479 | 2.100 |
Why?
| | Male | 147 | 2025 | 67762 | 1.980 |
Why?
| | Feces | 5 | 2025 | 484 | 1.900 |
Why?
| | Female | 150 | 2025 | 73304 | 1.860 |
Why?
| | Self-Injurious Behavior | 6 | 2020 | 130 | 1.840 |
Why?
| | Gastrointestinal Microbiome | 8 | 2025 | 697 | 1.810 |
Why?
| | Toxoplasmosis | 7 | 2025 | 40 | 1.750 |
Why?
| | RNA, Ribosomal, 16S | 5 | 2025 | 549 | 1.730 |
Why?
| | Toxoplasma | 6 | 2025 | 42 | 1.640 |
Why?
| | Activities of Daily Living | 4 | 2025 | 413 | 1.620 |
Why?
| | Afghan Campaign 2001- | 16 | 2024 | 132 | 1.600 |
Why?
| | Psychological Trauma | 3 | 2022 | 55 | 1.480 |
Why?
| | Sleep Initiation and Maintenance Disorders | 6 | 2024 | 165 | 1.470 |
Why?
| | Brain Injury, Chronic | 4 | 2016 | 23 | 1.340 |
Why?
| | Firearms | 9 | 2025 | 386 | 1.330 |
Why?
| | Health Personnel | 3 | 2021 | 710 | 1.290 |
Why?
| | Psychometrics | 11 | 2024 | 720 | 1.270 |
Why?
| | Aged | 52 | 2025 | 23961 | 1.250 |
Why?
| | Sleep Wake Disorders | 5 | 2022 | 286 | 1.210 |
Why?
| | Mental Health Services | 10 | 2024 | 421 | 1.160 |
Why?
| | Surveys and Questionnaires | 22 | 2025 | 5778 | 1.160 |
Why?
| | Healthcare Disparities | 2 | 2025 | 654 | 1.140 |
Why?
| | Qualitative Research | 13 | 2025 | 1386 | 1.120 |
Why?
| | Young Adult | 45 | 2025 | 13209 | 1.090 |
Why?
| | Violence | 6 | 2025 | 266 | 1.070 |
Why?
| | Social Determinants of Health | 2 | 2023 | 267 | 1.050 |
Why?
| | Depressive Disorder | 5 | 2024 | 379 | 1.050 |
Why?
| | Ambulatory Care | 4 | 2025 | 546 | 1.040 |
Why?
| | Impulsive Behavior | 7 | 2025 | 150 | 0.990 |
Why?
| | Health Promotion | 5 | 2019 | 741 | 0.980 |
Why?
| | Risk Factors | 38 | 2025 | 10388 | 0.970 |
Why?
| | Hyperbaric Oxygenation | 3 | 2015 | 39 | 0.970 |
Why?
| | Cross-Sectional Studies | 24 | 2025 | 5472 | 0.950 |
Why?
| | Antidepressive Agents | 7 | 2025 | 236 | 0.930 |
Why?
| | Pandemics | 5 | 2023 | 1639 | 0.920 |
Why?
| | Aftercare | 3 | 2021 | 208 | 0.920 |
Why?
| | Inpatients | 6 | 2025 | 500 | 0.880 |
Why?
| | Patient Discharge | 6 | 2025 | 897 | 0.870 |
Why?
| | Severity of Illness Index | 14 | 2021 | 2828 | 0.860 |
Why?
| | Specimen Handling | 1 | 2025 | 183 | 0.860 |
Why?
| | DNA, Bacterial | 2 | 2024 | 337 | 0.820 |
Why?
| | Mass Screening | 9 | 2025 | 1287 | 0.800 |
Why?
| | Retrospective Studies | 22 | 2025 | 15657 | 0.780 |
Why?
| | Transition to Adult Care | 1 | 2024 | 91 | 0.780 |
Why?
| | Evidence-Based Medicine | 4 | 2023 | 740 | 0.780 |
Why?
| | Head Injuries, Closed | 1 | 2022 | 48 | 0.770 |
Why?
| | Physical Therapy Specialty | 1 | 2023 | 52 | 0.760 |
Why?
| | Substance-Related Disorders | 5 | 2023 | 1083 | 0.760 |
Why?
| | Bacteria | 3 | 2025 | 858 | 0.750 |
Why?
| | Cerebral Palsy | 1 | 2024 | 107 | 0.750 |
Why?
| | Probiotics | 2 | 2025 | 54 | 0.740 |
Why?
| | Longitudinal Studies | 15 | 2025 | 2844 | 0.740 |
Why?
| | Drug Overdose | 2 | 2023 | 347 | 0.740 |
Why?
| | Residence Characteristics | 1 | 2025 | 351 | 0.740 |
Why?
| | Personality Assessment | 4 | 2017 | 84 | 0.730 |
Why?
| | Nutritional Status | 1 | 2024 | 350 | 0.720 |
Why?
| | Psychotherapy | 3 | 2017 | 167 | 0.710 |
Why?
| | Sequence Analysis, DNA | 1 | 2024 | 812 | 0.700 |
Why?
| | Occupational Diseases | 2 | 2020 | 156 | 0.700 |
Why?
| | Cohort Studies | 16 | 2021 | 5742 | 0.700 |
Why?
| | Stroke Rehabilitation | 1 | 2021 | 42 | 0.690 |
Why?
| | Risk Assessment | 18 | 2025 | 3457 | 0.680 |
Why?
| | Outpatients | 3 | 2025 | 396 | 0.680 |
Why?
| | Models, Psychological | 1 | 2022 | 301 | 0.660 |
Why?
| | Spinal Cord Injuries | 2 | 2022 | 212 | 0.650 |
Why?
| | Disability Evaluation | 6 | 2019 | 290 | 0.650 |
Why?
| | Adaptation, Psychological | 7 | 2018 | 655 | 0.650 |
Why?
| | Neuropsychological Tests | 9 | 2024 | 1023 | 0.640 |
Why?
| | Dysbiosis | 2 | 2018 | 181 | 0.640 |
Why?
| | Air Pollutants | 1 | 2024 | 430 | 0.610 |
Why?
| | Depression | 7 | 2025 | 1397 | 0.600 |
Why?
| | Animal Assisted Therapy | 1 | 2018 | 11 | 0.590 |
Why?
| | Safety | 2 | 2020 | 338 | 0.590 |
Why?
| | Patient Readmission | 1 | 2024 | 697 | 0.590 |
Why?
| | Porphyromonas gingivalis | 3 | 2025 | 23 | 0.590 |
Why?
| | Pets | 1 | 2018 | 26 | 0.590 |
Why?
| | Death Certificates | 2 | 2023 | 30 | 0.590 |
Why?
| | Antibodies, Protozoan | 5 | 2025 | 36 | 0.580 |
Why?
| | Hospitalization | 6 | 2025 | 2199 | 0.580 |
Why?
| | Wounds, Gunshot | 5 | 2023 | 228 | 0.580 |
Why?
| | Sense of Coherence | 1 | 2018 | 11 | 0.570 |
Why?
| | Hope | 1 | 2018 | 22 | 0.570 |
Why?
| | Adolescent | 22 | 2025 | 21513 | 0.570 |
Why?
| | Triage | 1 | 2020 | 222 | 0.560 |
Why?
| | Child Development | 1 | 2022 | 475 | 0.560 |
Why?
| | Hospitals, Veterans | 7 | 2022 | 252 | 0.550 |
Why?
| | Mobile Applications | 1 | 2020 | 183 | 0.550 |
Why?
| | Risk | 5 | 2023 | 912 | 0.540 |
Why?
| | Drug Packaging | 1 | 2017 | 45 | 0.540 |
Why?
| | Patient Acceptance of Health Care | 4 | 2024 | 806 | 0.540 |
Why?
| | Machine Learning | 5 | 2025 | 493 | 0.530 |
Why?
| | Psychotherapy, Group | 1 | 2017 | 66 | 0.530 |
Why?
| | Cognition Disorders | 3 | 2014 | 496 | 0.520 |
Why?
| | Parkinson Disease | 1 | 2022 | 493 | 0.520 |
Why?
| | Child Abuse | 1 | 2022 | 535 | 0.520 |
Why?
| | Inflammation | 7 | 2022 | 2837 | 0.510 |
Why?
| | Protective Factors | 2 | 2015 | 93 | 0.510 |
Why?
| | Problem Solving | 1 | 2017 | 152 | 0.500 |
Why?
| | Multiple Trauma | 2 | 2024 | 100 | 0.500 |
Why?
| | Caregivers | 1 | 2024 | 877 | 0.500 |
Why?
| | Executive Function | 4 | 2017 | 451 | 0.500 |
Why?
| | Patient Care Team | 3 | 2024 | 631 | 0.490 |
Why?
| | Home Care Services | 1 | 2019 | 257 | 0.490 |
Why?
| | Postural Balance | 1 | 2018 | 215 | 0.490 |
Why?
| | Headache | 3 | 2022 | 147 | 0.490 |
Why?
| | Cause of Death | 2 | 2023 | 434 | 0.480 |
Why?
| | Sleep Apnea, Obstructive | 3 | 2024 | 293 | 0.480 |
Why?
| | Feasibility Studies | 6 | 2021 | 956 | 0.470 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.460 |
Why?
| | Comorbidity | 10 | 2025 | 1622 | 0.460 |
Why?
| | Coronavirus Infections | 1 | 2020 | 364 | 0.460 |
Why?
| | Self Report | 6 | 2017 | 827 | 0.450 |
Why?
| | Afghanistan | 3 | 2024 | 71 | 0.450 |
Why?
| | Immunoglobulin G | 6 | 2025 | 893 | 0.450 |
Why?
| | Reproducibility of Results | 10 | 2024 | 3284 | 0.440 |
Why?
| | Combat Disorders | 2 | 2017 | 37 | 0.440 |
Why?
| | Psychiatric Status Rating Scales | 7 | 2025 | 547 | 0.420 |
Why?
| | Medication Adherence | 1 | 2017 | 467 | 0.420 |
Why?
| | Quality Improvement | 2 | 2020 | 1178 | 0.420 |
Why?
| | Case-Control Studies | 8 | 2022 | 3556 | 0.410 |
Why?
| | Recovery of Function | 5 | 2024 | 653 | 0.410 |
Why?
| | Health Planning | 1 | 2013 | 47 | 0.410 |
Why?
| | Iraq | 2 | 2024 | 53 | 0.410 |
Why?
| | Neuropsychology | 2 | 2011 | 37 | 0.410 |
Why?
| | Hypertension | 1 | 2022 | 1295 | 0.400 |
Why?
| | Risk Management | 1 | 2014 | 93 | 0.400 |
Why?
| | Aggression | 5 | 2025 | 202 | 0.400 |
Why?
| | Athletic Injuries | 1 | 2019 | 529 | 0.390 |
Why?
| | Emotions | 1 | 2018 | 548 | 0.390 |
Why?
| | Trauma Severity Indices | 5 | 2019 | 106 | 0.390 |
Why?
| | Observational Studies as Topic | 2 | 2024 | 117 | 0.390 |
Why?
| | Anxiety Disorders | 1 | 2016 | 377 | 0.390 |
Why?
| | Social Support | 5 | 2024 | 618 | 0.380 |
Why?
| | Interpersonal Relations | 1 | 2015 | 397 | 0.370 |
Why?
| | Stress, Physiological | 1 | 2015 | 443 | 0.370 |
Why?
| | Prevalence | 10 | 2025 | 2734 | 0.370 |
Why?
| | Quality of Life | 5 | 2019 | 2892 | 0.360 |
Why?
| | Telemedicine | 1 | 2020 | 862 | 0.360 |
Why?
| | Colorado | 6 | 2024 | 4565 | 0.350 |
Why?
| | Attitude of Health Personnel | 2 | 2016 | 1171 | 0.350 |
Why?
| | Wounds and Injuries | 1 | 2018 | 758 | 0.350 |
Why?
| | Aged, 80 and over | 7 | 2021 | 7635 | 0.340 |
Why?
| | Post-Traumatic Headache | 2 | 2020 | 5 | 0.340 |
Why?
| | Ethanol | 3 | 2024 | 608 | 0.340 |
Why?
| | Bayes Theorem | 2 | 2022 | 405 | 0.330 |
Why?
| | Interviews as Topic | 6 | 2025 | 786 | 0.330 |
Why?
| | Socioeconomic Factors | 6 | 2023 | 1289 | 0.330 |
Why?
| | Sex Offenses | 2 | 2023 | 196 | 0.320 |
Why?
| | United States Department of Defense | 2 | 2025 | 12 | 0.320 |
Why?
| | Terminology as Topic | 1 | 2011 | 216 | 0.320 |
Why?
| | Tryptophan | 3 | 2022 | 183 | 0.310 |
Why?
| | Nervous System Diseases | 2 | 2025 | 266 | 0.310 |
Why?
| | Crisis Intervention | 3 | 2024 | 33 | 0.300 |
Why?
| | Diagnostic Imaging | 2 | 2011 | 332 | 0.300 |
Why?
| | Amish | 2 | 2019 | 7 | 0.300 |
Why?
| | Dizziness | 2 | 2019 | 82 | 0.300 |
Why?
| | Quality of Health Care | 1 | 2013 | 642 | 0.290 |
Why?
| | Housing | 2 | 2020 | 146 | 0.290 |
Why?
| | Public Health | 5 | 2022 | 588 | 0.290 |
Why?
| | Program Evaluation | 3 | 2024 | 898 | 0.290 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2024 | 1477 | 0.290 |
Why?
| | Stress, Psychological | 2 | 2020 | 1100 | 0.290 |
Why?
| | Sleep | 3 | 2024 | 755 | 0.280 |
Why?
| | Intention | 1 | 2009 | 170 | 0.280 |
Why?
| | Cognitive Dysfunction | 1 | 2013 | 383 | 0.280 |
Why?
| | Emergency Medical Services | 2 | 2023 | 552 | 0.270 |
Why?
| | Pregnancy Trimester, First | 2 | 2025 | 140 | 0.270 |
Why?
| | Kynurenine | 3 | 2018 | 114 | 0.270 |
Why?
| | Neuropsychiatry | 2 | 2020 | 17 | 0.270 |
Why?
| | Age Factors | 6 | 2024 | 3295 | 0.260 |
Why?
| | Health Behavior | 1 | 2012 | 762 | 0.260 |
Why?
| | Environment, Controlled | 2 | 2016 | 22 | 0.250 |
Why?
| | Emergency Service, Hospital | 6 | 2020 | 2069 | 0.250 |
Why?
| | Time Factors | 7 | 2019 | 6828 | 0.250 |
Why?
| | Hotlines | 4 | 2024 | 32 | 0.250 |
Why?
| | Treatment Outcome | 11 | 2022 | 10811 | 0.240 |
Why?
| | Factor Analysis, Statistical | 4 | 2024 | 283 | 0.240 |
Why?
| | Prospective Studies | 10 | 2025 | 7604 | 0.240 |
Why?
| | Follow-Up Studies | 5 | 2022 | 5131 | 0.240 |
Why?
| | Rehabilitation Research | 1 | 2025 | 7 | 0.240 |
Why?
| | Common Data Elements | 1 | 2025 | 14 | 0.230 |
Why?
| | Rehabilitation Centers | 2 | 2024 | 39 | 0.230 |
Why?
| | Neurological Rehabilitation | 1 | 2025 | 9 | 0.230 |
Why?
| | Social Participation | 1 | 2025 | 27 | 0.230 |
Why?
| | Drug Storage | 1 | 2025 | 57 | 0.230 |
Why?
| | Motivation | 1 | 2009 | 570 | 0.230 |
Why?
| | Delay Discounting | 1 | 2024 | 23 | 0.220 |
Why?
| | Affect | 2 | 2018 | 292 | 0.220 |
Why?
| | Antibodies, Bacterial | 1 | 2025 | 146 | 0.220 |
Why?
| | Decision Making | 3 | 2024 | 900 | 0.220 |
Why?
| | Logistic Models | 7 | 2025 | 2074 | 0.220 |
Why?
| | Complementary Therapies | 2 | 2016 | 88 | 0.220 |
Why?
| | Lomustine | 1 | 2024 | 14 | 0.220 |
Why?
| | Policy | 2 | 2022 | 150 | 0.220 |
Why?
| | Primary Health Care | 2 | 2025 | 1738 | 0.220 |
Why?
| | Patient Health Questionnaire | 1 | 2024 | 37 | 0.220 |
Why?
| | Mouth | 1 | 2024 | 87 | 0.210 |
Why?
| | Anxiety | 4 | 2025 | 1035 | 0.210 |
Why?
| | Sensitivity and Specificity | 4 | 2013 | 1946 | 0.210 |
Why?
| | Metals, Heavy | 1 | 2024 | 31 | 0.210 |
Why?
| | Sex Distribution | 2 | 2023 | 375 | 0.210 |
Why?
| | Pesticides | 1 | 2024 | 62 | 0.210 |
Why?
| | Irritable Bowel Syndrome | 1 | 2023 | 28 | 0.210 |
Why?
| | Natural Language Processing | 1 | 2025 | 95 | 0.210 |
Why?
| | Prognosis | 3 | 2024 | 4030 | 0.210 |
Why?
| | Wildfires | 1 | 2024 | 42 | 0.200 |
Why?
| | Clinical Protocols | 2 | 2015 | 271 | 0.200 |
Why?
| | Global Burden of Disease | 1 | 2023 | 24 | 0.200 |
Why?
| | Psychiatric Department, Hospital | 2 | 2014 | 13 | 0.200 |
Why?
| | Transportation of Patients | 1 | 2023 | 55 | 0.200 |
Why?
| | Prednisone | 1 | 2024 | 240 | 0.200 |
Why?
| | Abruptio Placentae | 1 | 2022 | 5 | 0.200 |
Why?
| | Disaster Planning | 1 | 2024 | 91 | 0.200 |
Why?
| | Disasters | 1 | 2024 | 98 | 0.200 |
Why?
| | Interview, Psychological | 2 | 2015 | 96 | 0.200 |
Why?
| | Ohio | 1 | 2022 | 152 | 0.190 |
Why?
| | Pharmacogenomic Testing | 1 | 2022 | 64 | 0.190 |
Why?
| | Inappropriate Prescribing | 1 | 2022 | 55 | 0.180 |
Why?
| | Schizophrenia | 2 | 2016 | 439 | 0.180 |
Why?
| | Neopterin | 2 | 2022 | 12 | 0.180 |
Why?
| | Incidence | 6 | 2019 | 2804 | 0.180 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2024 | 1329 | 0.180 |
Why?
| | Physician-Patient Relations | 2 | 2025 | 548 | 0.180 |
Why?
| | Subacute Care | 1 | 2022 | 79 | 0.180 |
Why?
| | Meta-Analysis as Topic | 1 | 2022 | 186 | 0.180 |
Why?
| | Hepatic Encephalopathy | 1 | 2021 | 21 | 0.170 |
Why?
| | Pilot Projects | 5 | 2024 | 1710 | 0.170 |
Why?
| | Drug Interactions | 1 | 2022 | 410 | 0.170 |
Why?
| | Frailty | 1 | 2024 | 170 | 0.170 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2025 | 394 | 0.170 |
Why?
| | HIV Infections | 1 | 2015 | 2836 | 0.170 |
Why?
| | Cost of Illness | 1 | 2023 | 308 | 0.170 |
Why?
| | Skin | 2 | 2023 | 752 | 0.170 |
Why?
| | Skilled Nursing Facilities | 1 | 2022 | 141 | 0.170 |
Why?
| | Parenting | 1 | 2024 | 310 | 0.170 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2024 | 539 | 0.170 |
Why?
| | Anger | 3 | 2021 | 60 | 0.170 |
Why?
| | Proteome | 1 | 2025 | 472 | 0.170 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 4 | 2016 | 243 | 0.170 |
Why?
| | Air Pollution | 1 | 2024 | 316 | 0.170 |
Why?
| | Pregnancy Complications | 1 | 2025 | 527 | 0.160 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2021 | 89 | 0.160 |
Why?
| | Seasonal Affective Disorder | 1 | 2020 | 11 | 0.160 |
Why?
| | Photophobia | 1 | 2019 | 10 | 0.160 |
Why?
| | Hyperacusis | 1 | 2019 | 8 | 0.160 |
Why?
| | Receptors, Calcitriol | 1 | 2020 | 55 | 0.160 |
Why?
| | Hypesthesia | 1 | 2019 | 17 | 0.160 |
Why?
| | Survival Analysis | 3 | 2011 | 1325 | 0.160 |
Why?
| | Communicable Diseases | 1 | 2022 | 159 | 0.160 |
Why?
| | Environment Design | 2 | 2016 | 27 | 0.160 |
Why?
| | Hippocampus | 1 | 2025 | 895 | 0.160 |
Why?
| | Health Services Needs and Demand | 1 | 2021 | 273 | 0.160 |
Why?
| | Vitamin D Deficiency | 1 | 2021 | 186 | 0.160 |
Why?
| | Sex Factors | 6 | 2024 | 2071 | 0.160 |
Why?
| | Periodontitis | 1 | 2020 | 53 | 0.160 |
Why?
| | Paresis | 1 | 2019 | 30 | 0.160 |
Why?
| | Arm Injuries | 1 | 2019 | 26 | 0.150 |
Why?
| | Chronic Traumatic Encephalopathy | 1 | 2019 | 17 | 0.150 |
Why?
| | Morals | 1 | 2020 | 82 | 0.150 |
Why?
| | Environmental Exposure | 1 | 2024 | 579 | 0.150 |
Why?
| | Occupational Injuries | 1 | 2019 | 44 | 0.150 |
Why?
| | Alcoholism | 2 | 2024 | 807 | 0.150 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2023 | 351 | 0.150 |
Why?
| | Odds Ratio | 5 | 2016 | 1070 | 0.150 |
Why?
| | Medical Staff, Hospital | 1 | 2019 | 83 | 0.150 |
Why?
| | Environmental Microbiology | 1 | 2019 | 53 | 0.150 |
Why?
| | Premature Birth | 1 | 2022 | 333 | 0.150 |
Why?
| | Arm | 1 | 2019 | 104 | 0.150 |
Why?
| | Patient-Centered Care | 1 | 2024 | 530 | 0.150 |
Why?
| | Delirium | 2 | 2011 | 92 | 0.150 |
Why?
| | Fatigue | 2 | 2018 | 329 | 0.150 |
Why?
| | Psychotherapy, Brief | 1 | 2018 | 34 | 0.140 |
Why?
| | Liver Cirrhosis | 1 | 2021 | 316 | 0.140 |
Why?
| | Diet | 2 | 2023 | 1278 | 0.140 |
Why?
| | Food Supply | 1 | 2019 | 83 | 0.140 |
Why?
| | Cross-Over Studies | 2 | 2018 | 564 | 0.140 |
Why?
| | Health Services Research | 1 | 2021 | 404 | 0.140 |
Why?
| | Reproductive Health | 3 | 2024 | 90 | 0.140 |
Why?
| | Women's Health | 1 | 2021 | 372 | 0.140 |
Why?
| | Phenylalanine | 1 | 2018 | 68 | 0.140 |
Why?
| | Adiponectin | 1 | 2020 | 244 | 0.140 |
Why?
| | Child | 5 | 2024 | 21935 | 0.140 |
Why?
| | Tyrosine | 1 | 2018 | 222 | 0.130 |
Why?
| | Dogs | 1 | 2018 | 413 | 0.130 |
Why?
| | Prefrontal Cortex | 2 | 2017 | 301 | 0.130 |
Why?
| | Confidence Intervals | 3 | 2016 | 329 | 0.130 |
Why?
| | Prebiotics | 1 | 2017 | 27 | 0.130 |
Why?
| | Electronic Health Records | 1 | 2025 | 1069 | 0.130 |
Why?
| | Gliadin | 1 | 2016 | 13 | 0.130 |
Why?
| | Amygdala | 2 | 2017 | 191 | 0.130 |
Why?
| | Patient Selection | 1 | 2020 | 696 | 0.130 |
Why?
| | Disease Models, Animal | 2 | 2017 | 4295 | 0.130 |
Why?
| | Databases, Factual | 1 | 2022 | 1357 | 0.120 |
Why?
| | Housing, Animal | 1 | 2016 | 46 | 0.120 |
Why?
| | Physical Therapy Modalities | 1 | 2019 | 308 | 0.120 |
Why?
| | Rural Population | 1 | 2020 | 563 | 0.120 |
Why?
| | Social Work, Psychiatric | 1 | 2015 | 3 | 0.120 |
Why?
| | Community Mental Health Centers | 1 | 2015 | 13 | 0.120 |
Why?
| | Neuroimaging | 2 | 2017 | 259 | 0.120 |
Why?
| | Perception | 2 | 2019 | 359 | 0.120 |
Why?
| | Immunomodulation | 1 | 2016 | 98 | 0.120 |
Why?
| | Obesity | 2 | 2019 | 2992 | 0.120 |
Why?
| | Actigraphy | 1 | 2016 | 110 | 0.120 |
Why?
| | Prescription Drug Misuse | 1 | 2015 | 41 | 0.120 |
Why?
| | Medical Records | 1 | 2016 | 177 | 0.120 |
Why?
| | Counseling | 2 | 2023 | 391 | 0.120 |
Why?
| | Health Status Indicators | 2 | 2012 | 171 | 0.110 |
Why?
| | Israel | 2 | 2025 | 56 | 0.110 |
Why?
| | Needs Assessment | 2 | 2024 | 376 | 0.110 |
Why?
| | Propylamines | 1 | 2014 | 10 | 0.110 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2014 | 17 | 0.110 |
Why?
| | Analgesics, Opioid | 1 | 2023 | 1000 | 0.110 |
Why?
| | Delivery of Health Care | 4 | 2023 | 951 | 0.110 |
Why?
| | Guam | 2 | 2025 | 14 | 0.110 |
Why?
| | Thalamus | 1 | 2015 | 107 | 0.110 |
Why?
| | Mood Disorders | 1 | 2015 | 133 | 0.110 |
Why?
| | Cross-Cultural Comparison | 1 | 2014 | 86 | 0.110 |
Why?
| | Forecasting | 1 | 2016 | 389 | 0.110 |
Why?
| | Biomedical Research | 1 | 2020 | 692 | 0.110 |
Why?
| | Genes, p53 | 1 | 1993 | 72 | 0.110 |
Why?
| | Cerebellum | 1 | 2015 | 224 | 0.100 |
Why?
| | Analgesics | 1 | 2015 | 206 | 0.100 |
Why?
| | Forensic Psychiatry | 1 | 2013 | 28 | 0.100 |
Why?
| | Burnout, Professional | 1 | 2020 | 442 | 0.100 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2019 | 480 | 0.100 |
Why?
| | Self Concept | 1 | 2015 | 253 | 0.100 |
Why?
| | Chi-Square Distribution | 2 | 2011 | 530 | 0.100 |
Why?
| | Hawaii | 2 | 2024 | 34 | 0.100 |
Why?
| | Seroepidemiologic Studies | 3 | 2019 | 165 | 0.100 |
Why?
| | Australia | 1 | 2014 | 315 | 0.100 |
Why?
| | Patient Satisfaction | 1 | 2017 | 660 | 0.100 |
Why?
| | Stress Disorders, Traumatic | 1 | 2013 | 22 | 0.100 |
Why?
| | Employment | 1 | 2014 | 178 | 0.100 |
Why?
| | Sex | 1 | 2012 | 5 | 0.100 |
Why?
| | Linear Models | 3 | 2010 | 849 | 0.100 |
Why?
| | Multivariate Analysis | 2 | 2019 | 1509 | 0.100 |
Why?
| | Brain | 4 | 2021 | 2668 | 0.100 |
Why?
| | Coronary Artery Disease | 1 | 2019 | 698 | 0.100 |
Why?
| | Football | 1 | 2013 | 85 | 0.100 |
Why?
| | Decision Support Systems, Clinical | 1 | 2016 | 226 | 0.100 |
Why?
| | Computer Communication Networks | 1 | 2012 | 33 | 0.100 |
Why?
| | Advisory Committees | 1 | 2013 | 219 | 0.090 |
Why?
| | Algorithms | 3 | 2019 | 1704 | 0.090 |
Why?
| | Social Stigma | 1 | 2013 | 137 | 0.090 |
Why?
| | Infant | 2 | 2022 | 9465 | 0.090 |
Why?
| | Task Performance and Analysis | 2 | 2017 | 183 | 0.090 |
Why?
| | Therapy, Computer-Assisted | 1 | 2012 | 62 | 0.090 |
Why?
| | Statistics, Nonparametric | 2 | 2009 | 431 | 0.090 |
Why?
| | Signal Transduction | 1 | 2025 | 5079 | 0.090 |
Why?
| | Information Dissemination | 1 | 2013 | 218 | 0.090 |
Why?
| | Consciousness Disorders | 1 | 2011 | 20 | 0.090 |
Why?
| | Ethics, Professional | 1 | 2011 | 14 | 0.090 |
Why?
| | Interprofessional Relations | 1 | 2013 | 283 | 0.090 |
Why?
| | Transforming Growth Factor beta | 1 | 1993 | 480 | 0.090 |
Why?
| | Life Change Events | 1 | 2012 | 151 | 0.090 |
Why?
| | Pregnancy | 4 | 2025 | 6763 | 0.090 |
Why?
| | Walking | 1 | 2015 | 529 | 0.090 |
Why?
| | Psychomotor Agitation | 1 | 2011 | 71 | 0.080 |
Why?
| | Inservice Training | 1 | 2011 | 116 | 0.080 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 2031 | 0.080 |
Why?
| | Glucose | 1 | 2015 | 1020 | 0.080 |
Why?
| | Research | 1 | 2013 | 451 | 0.080 |
Why?
| | Health Policy | 1 | 2013 | 388 | 0.080 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 413 | 0.080 |
Why?
| | Health Plan Implementation | 1 | 2011 | 142 | 0.080 |
Why?
| | Interdisciplinary Communication | 1 | 2011 | 191 | 0.080 |
Why?
| | Life Style | 1 | 2012 | 490 | 0.080 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2011 | 153 | 0.080 |
Why?
| | Multiple Sclerosis | 1 | 2015 | 455 | 0.080 |
Why?
| | Irritable Mood | 2 | 2021 | 50 | 0.080 |
Why?
| | Explosions | 1 | 2009 | 9 | 0.080 |
Why?
| | Analysis of Variance | 2 | 2011 | 1316 | 0.080 |
Why?
| | Religion and Psychology | 1 | 2009 | 28 | 0.080 |
Why?
| | Elective Surgical Procedures | 1 | 2011 | 179 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1483 | 0.080 |
Why?
| | HIV-1 | 1 | 2015 | 864 | 0.080 |
Why?
| | Affective Symptoms | 1 | 2009 | 53 | 0.080 |
Why?
| | Patient Education as Topic | 1 | 2014 | 766 | 0.080 |
Why?
| | Data Collection | 1 | 2012 | 673 | 0.080 |
Why?
| | Neurologic Examination | 1 | 2009 | 110 | 0.080 |
Why?
| | Hypogonadism | 1 | 2009 | 92 | 0.070 |
Why?
| | Cooperative Behavior | 1 | 2011 | 451 | 0.070 |
Why?
| | Carcinoma, Squamous Cell | 1 | 1993 | 683 | 0.070 |
Why?
| | Proportional Hazards Models | 1 | 2011 | 1266 | 0.070 |
Why?
| | Animals | 6 | 2025 | 36940 | 0.070 |
Why?
| | Alcohol Drinking | 1 | 2014 | 828 | 0.070 |
Why?
| | Brain Mapping | 1 | 2011 | 503 | 0.070 |
Why?
| | Population Surveillance | 1 | 2011 | 482 | 0.070 |
Why?
| | Resilience, Psychological | 1 | 2009 | 128 | 0.070 |
Why?
| | Decision Support Techniques | 1 | 2011 | 421 | 0.070 |
Why?
| | Language Disorders | 1 | 2007 | 30 | 0.070 |
Why?
| | Glasgow Coma Scale | 3 | 2014 | 186 | 0.070 |
Why?
| | Aging | 1 | 2017 | 1864 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 852 | 0.060 |
Why?
| | Healthy Volunteers | 2 | 2018 | 199 | 0.060 |
Why?
| | Psychological Tests | 1 | 2007 | 140 | 0.060 |
Why?
| | Micronesia | 1 | 2025 | 7 | 0.060 |
Why?
| | American Samoa | 1 | 2025 | 8 | 0.060 |
Why?
| | Hostility | 1 | 2025 | 15 | 0.060 |
Why?
| | National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2025 | 5 | 0.060 |
Why?
| | Serogroup | 1 | 2025 | 44 | 0.060 |
Why?
| | Testosterone | 1 | 2009 | 409 | 0.060 |
Why?
| | Armed Conflicts | 1 | 2025 | 10 | 0.060 |
Why?
| | Terrorism | 1 | 2024 | 24 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 2 | 2024 | 3566 | 0.060 |
Why?
| | Reproductive Health Services | 1 | 2024 | 19 | 0.060 |
Why?
| | Warfare | 1 | 2025 | 68 | 0.060 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2024 | 60 | 0.060 |
Why?
| | Diffusion Tensor Imaging | 1 | 2024 | 79 | 0.050 |
Why?
| | Comparative Effectiveness Research | 1 | 2025 | 152 | 0.050 |
Why?
| | Social Change | 1 | 2024 | 15 | 0.050 |
Why?
| | Treatment Adherence and Compliance | 1 | 2024 | 26 | 0.050 |
Why?
| | Length of Stay | 1 | 2009 | 1215 | 0.050 |
Why?
| | Video Recording | 1 | 2024 | 180 | 0.050 |
Why?
| | Asphyxia | 1 | 2023 | 20 | 0.050 |
Why?
| | Frontal Lobe | 1 | 2024 | 149 | 0.050 |
Why?
| | Cognition | 2 | 2022 | 1153 | 0.050 |
Why?
| | Friends | 1 | 2023 | 52 | 0.050 |
Why?
| | Fertility | 1 | 2024 | 160 | 0.050 |
Why?
| | Choice Behavior | 1 | 2024 | 170 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 1692 | 0.050 |
Why?
| | Biomarkers | 2 | 2024 | 4149 | 0.050 |
Why?
| | Administration, Oral | 1 | 2025 | 816 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2024 | 289 | 0.050 |
Why?
| | Stillbirth | 1 | 2022 | 72 | 0.050 |
Why?
| | Public Opinion | 1 | 2022 | 65 | 0.050 |
Why?
| | Ownership | 1 | 2022 | 94 | 0.050 |
Why?
| | Remission Induction | 1 | 2022 | 288 | 0.050 |
Why?
| | Social Justice | 1 | 2022 | 73 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2023 | 347 | 0.040 |
Why?
| | Pharmacogenetics | 1 | 2022 | 180 | 0.040 |
Why?
| | Postoperative Complications | 2 | 2011 | 2654 | 0.040 |
Why?
| | Research Report | 1 | 2021 | 83 | 0.040 |
Why?
| | Nursing Homes | 1 | 2022 | 181 | 0.040 |
Why?
| | Cathelicidins | 1 | 2020 | 41 | 0.040 |
Why?
| | Internet | 1 | 2024 | 655 | 0.040 |
Why?
| | Lithium Compounds | 1 | 2019 | 12 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2015 | 1993 | 0.040 |
Why?
| | Patient Compliance | 1 | 2024 | 581 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2012 | 2253 | 0.040 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2020 | 81 | 0.040 |
Why?
| | Central Nervous System | 1 | 2021 | 258 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2022 | 322 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 1 | 2025 | 2486 | 0.040 |
Why?
| | September 11 Terrorist Attacks | 1 | 2019 | 32 | 0.040 |
Why?
| | Retirement | 1 | 2019 | 31 | 0.040 |
Why?
| | Disease Progression | 2 | 2017 | 2757 | 0.040 |
Why?
| | Ketamine | 1 | 2019 | 94 | 0.040 |
Why?
| | Wakefulness | 1 | 2019 | 125 | 0.040 |
Why?
| | Patient Preference | 1 | 2020 | 191 | 0.040 |
Why?
| | Research Design | 2 | 2015 | 1139 | 0.040 |
Why?
| | Serologic Tests | 1 | 2018 | 54 | 0.040 |
Why?
| | Proteomics | 1 | 2025 | 1111 | 0.040 |
Why?
| | Attitude | 1 | 2020 | 259 | 0.040 |
Why?
| | Germany | 1 | 2018 | 121 | 0.040 |
Why?
| | Memory Disorders | 1 | 2019 | 164 | 0.030 |
Why?
| | Nutrition Surveys | 1 | 2019 | 266 | 0.030 |
Why?
| | War-Related Injuries | 1 | 2017 | 9 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 660 | 0.030 |
Why?
| | Seasons | 1 | 2020 | 547 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2019 | 264 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2022 | 786 | 0.030 |
Why?
| | RNA, Bacterial | 1 | 2017 | 190 | 0.030 |
Why?
| | Behavioral Risk Factor Surveillance System | 1 | 2016 | 53 | 0.030 |
Why?
| | Organ Size | 1 | 2017 | 477 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1236 | 0.030 |
Why?
| | Sick Building Syndrome | 1 | 2015 | 4 | 0.030 |
Why?
| | Rats | 1 | 2025 | 5647 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 1 | 2025 | 1313 | 0.030 |
Why?
| | Receptors, Dopamine | 1 | 1996 | 20 | 0.030 |
Why?
| | Dopamine Antagonists | 1 | 1996 | 27 | 0.030 |
Why?
| | Placenta | 1 | 2022 | 750 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2018 | 597 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 1996 | 80 | 0.030 |
Why?
| | Pyrrolidines | 1 | 1996 | 79 | 0.030 |
Why?
| | Iodine Radioisotopes | 1 | 1996 | 145 | 0.030 |
Why?
| | Psychological Techniques | 1 | 2014 | 7 | 0.030 |
Why?
| | Poverty | 1 | 2019 | 521 | 0.030 |
Why?
| | Dopamine | 1 | 2018 | 303 | 0.030 |
Why?
| | Environment | 1 | 2017 | 358 | 0.030 |
Why?
| | Benzamides | 1 | 1996 | 216 | 0.030 |
Why?
| | Reward | 1 | 2017 | 244 | 0.030 |
Why?
| | Community Mental Health Services | 1 | 2015 | 84 | 0.030 |
Why?
| | Atomoxetine Hydrochloride | 1 | 2014 | 6 | 0.030 |
Why?
| | Radiopharmaceuticals | 1 | 2015 | 178 | 0.030 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2015 | 135 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1502 | 0.030 |
Why?
| | Florida | 1 | 2014 | 107 | 0.030 |
Why?
| | Body Weight | 1 | 2019 | 985 | 0.030 |
Why?
| | Risk-Taking | 1 | 2017 | 348 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2015 | 294 | 0.030 |
Why?
| | Antipsychotic Agents | 1 | 1996 | 194 | 0.030 |
Why?
| | Health Surveys | 1 | 2015 | 514 | 0.030 |
Why?
| | Piperazines | 1 | 1996 | 350 | 0.030 |
Why?
| | Drug Resistance | 1 | 1993 | 169 | 0.030 |
Why?
| | Personality | 1 | 2014 | 132 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2019 | 1431 | 0.020 |
Why?
| | Focus Groups | 1 | 2015 | 522 | 0.020 |
Why?
| | Suramin | 1 | 2012 | 8 | 0.020 |
Why?
| | Pain Measurement | 1 | 2015 | 521 | 0.020 |
Why?
| | Exercise Test | 1 | 2015 | 625 | 0.020 |
Why?
| | Leukopenia | 1 | 2012 | 31 | 0.020 |
Why?
| | Genetic Vectors | 1 | 1993 | 319 | 0.020 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2012 | 87 | 0.020 |
Why?
| | Taxoids | 1 | 2012 | 102 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 1993 | 955 | 0.020 |
Why?
| | Nausea | 1 | 2012 | 111 | 0.020 |
Why?
| | Health Priorities | 1 | 2012 | 44 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2012 | 2057 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2012 | 307 | 0.020 |
Why?
| | Ethical Review | 1 | 2011 | 3 | 0.020 |
Why?
| | Phenotype | 1 | 2020 | 3196 | 0.020 |
Why?
| | Wheelchairs | 1 | 2011 | 16 | 0.020 |
Why?
| | Paclitaxel | 1 | 2012 | 230 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2022 | 6079 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 686 | 0.020 |
Why?
| | Personal Autonomy | 1 | 2011 | 49 | 0.020 |
Why?
| | Age Distribution | 1 | 2011 | 392 | 0.020 |
Why?
| | Medical History Taking | 1 | 2010 | 117 | 0.020 |
Why?
| | Personal Satisfaction | 1 | 2012 | 207 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 786 | 0.020 |
Why?
| | Base Sequence | 1 | 1993 | 2181 | 0.020 |
Why?
| | Dementia | 1 | 2013 | 259 | 0.020 |
Why?
| | Reference Values | 1 | 2011 | 816 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2012 | 658 | 0.020 |
Why?
| | Pain | 1 | 2015 | 756 | 0.020 |
Why?
| | False Negative Reactions | 1 | 2009 | 53 | 0.020 |
Why?
| | Injury Severity Score | 1 | 2011 | 522 | 0.020 |
Why?
| | Geriatric Assessment | 1 | 2011 | 224 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 1993 | 2900 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2009 | 115 | 0.020 |
Why?
| | Self Efficacy | 1 | 2012 | 396 | 0.020 |
Why?
| | Preoperative Care | 1 | 2011 | 362 | 0.020 |
Why?
| | Head and Neck Neoplasms | 1 | 1993 | 606 | 0.020 |
Why?
| | ROC Curve | 1 | 2009 | 554 | 0.020 |
Why?
| | Health Status | 1 | 2012 | 792 | 0.020 |
Why?
| | Survival Rate | 1 | 2011 | 1972 | 0.020 |
Why?
| | Cell Differentiation | 1 | 1993 | 1991 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1587 | 0.010 |
Why?
| | Mice | 1 | 2016 | 17787 | 0.010 |
Why?
| | Receptors, Dopamine D2 | 1 | 1996 | 97 | 0.010 |
Why?
| | Infusions, Intravenous | 1 | 1996 | 413 | 0.010 |
Why?
| | Corpus Striatum | 1 | 1996 | 167 | 0.010 |
Why?
| | Contrast Media | 1 | 1996 | 467 | 0.010 |
Why?
|
|
Brenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|